MedPath

Covalon Technologies Inc

๐Ÿ‡จ๐Ÿ‡ฆCanada
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:0
Completed:3

Trial Phases

2 Phases

Phase 1:2
Not Applicable:2

Drug Approvals

4

CANADA:2

Drug Approvals

COVALONGUARD SPRAY

Approval Date
Jun 26, 2020
CANADA

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)โ€ข Click on a phase to view related trials

Not Applicable
2 (50.0%)
Phase 1
2 (50.0%)

HRIPT for Collagen Dressing

Not Applicable
Completed
Conditions
Skin Sensitisation
First Posted Date
2024-02-28
Last Posted Date
2025-03-12
Lead Sponsor
Covalon Technologies Inc.
Target Recruit Count
86
Registration Number
NCT06283173
Locations
๐Ÿ‡บ๐Ÿ‡ธ

ALS Beauty and Personal Care, Torrance, California, United States

SPT for Sensitization of Collagen Dressing

Not Applicable
Recruiting
Conditions
Allergy Skin
Allergic Skin Reaction
First Posted Date
2024-02-22
Last Posted Date
2024-02-23
Lead Sponsor
Covalon Technologies Inc.
Target Recruit Count
30
Registration Number
NCT06271993
Locations
๐Ÿ‡บ๐Ÿ‡ธ

ALS Beauty and Personal Care, Torrance, California, United States

Antimicrobial Activity of IV Clearโ„ข Dressing - Prevention of Antimicrobial Regrowth

Phase 1
Completed
Conditions
Skin Flora Infection
First Posted Date
2011-06-07
Last Posted Date
2015-04-16
Lead Sponsor
Covalon Technologies Inc.
Target Recruit Count
37
Registration Number
NCT01368120
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Hill Top Research, Miamiville, Ohio, United States

Human Repeat Insult Patch Test of Wound Dressings

Phase 1
Completed
Conditions
Skin Sensitization
First Posted Date
2011-06-07
Last Posted Date
2025-03-25
Lead Sponsor
Covalon Technologies Inc.
Target Recruit Count
216
Registration Number
NCT01368146
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Hill Top Research, Saint Petersburg, Florida, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.